SG11202100006QA - Method for isolating a cardiomyocyte population - Google Patents

Method for isolating a cardiomyocyte population

Info

Publication number
SG11202100006QA
SG11202100006QA SG11202100006QA SG11202100006QA SG11202100006QA SG 11202100006Q A SG11202100006Q A SG 11202100006QA SG 11202100006Q A SG11202100006Q A SG 11202100006QA SG 11202100006Q A SG11202100006Q A SG 11202100006QA SG 11202100006Q A SG11202100006Q A SG 11202100006QA
Authority
SG
Singapore
Prior art keywords
isolating
cardiomyocyte population
cardiomyocyte
population
Prior art date
Application number
SG11202100006QA
Other languages
English (en)
Inventor
Boon Seng Soh
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Publication of SG11202100006QA publication Critical patent/SG11202100006QA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
SG11202100006QA 2018-07-16 2019-07-16 Method for isolating a cardiomyocyte population SG11202100006QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG10201806072Q 2018-07-16
PCT/SG2019/050346 WO2020018019A1 (fr) 2018-07-16 2019-07-16 Procédé d'isolement d'une population de cardiomyocytes

Publications (1)

Publication Number Publication Date
SG11202100006QA true SG11202100006QA (en) 2021-01-28

Family

ID=69164110

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202100006QA SG11202100006QA (en) 2018-07-16 2019-07-16 Method for isolating a cardiomyocyte population

Country Status (4)

Country Link
US (1) US20210317412A1 (fr)
CN (1) CN112424340B (fr)
SG (1) SG11202100006QA (fr)
WO (1) WO2020018019A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4013494A1 (fr) 2019-08-12 2022-06-22 Regeneron Pharmaceuticals, Inc. Variants du récepteur 1 de la stimulation des macrophages (mst1r) et leurs utilisations
WO2023134715A1 (fr) * 2022-01-12 2023-07-20 中国医学科学院阜外医院 Réactif d'isolation de cardiomyocytes et procédé d'isolation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2477705B (en) * 2008-11-17 2014-04-23 Veracyte Inc Methods and compositions of molecular profiling for disease diagnostics
US20110030072A1 (en) * 2008-12-04 2011-02-03 Sigma-Aldrich Co. Genome editing of immunodeficiency genes in animals
CN102858985A (zh) * 2009-07-24 2013-01-02 西格马-奥尔德里奇有限责任公司 基因组编辑方法
EP2580317B1 (fr) * 2010-06-13 2020-12-23 Institute of Biophysics Chinese Academy of Sciences Procédés et compositions pour préparer des cardiomyocytes à partir de cellules souches et leurs utilisations
CN105188767A (zh) * 2012-07-25 2015-12-23 布罗德研究所有限公司 可诱导的dna结合蛋白和基因组干扰工具及其应用
ES2689804T3 (es) * 2013-11-20 2018-11-15 Miltenyi Biotec Gmbh Composiciones de subpoblaciones de cardiomiocitos
US10561687B2 (en) * 2015-02-17 2020-02-18 University Health Network Methods for making and using sinoatrial node-like pacemaker cardiomyocytes and ventricular-like cardiomyocytes
WO2016201129A1 (fr) * 2015-06-09 2016-12-15 President And Fellows Of Harvard College Compositions et procédés pour l'enrichissement de cellules
US11390851B2 (en) * 2016-06-01 2022-07-19 Miltenyi Biotec B.V. & Co. KG Process for generation, identification and isolation of human pluripotent stem cell-derived cardiomyocytes and cardiomyocyte subpopulations
IT201700062176A1 (it) * 2017-06-07 2018-12-07 Univ Degli Studi Milano Metodo per l’isolamento di sottopopolazioni di progenitori cellulari cardiaci e relativi usi in campo medico

Also Published As

Publication number Publication date
CN112424340A (zh) 2021-02-26
WO2020018019A1 (fr) 2020-01-23
US20210317412A1 (en) 2021-10-14
CN112424340B (zh) 2024-03-19

Similar Documents

Publication Publication Date Title
EP3762743C0 (fr) Procédé pour faire fonctionner une installation
GB201800298D0 (en) Method
SG11202107482SA (en) Method for constructing structure
ZA202005229B (en) Method for erecting a lift facility
GB201805954D0 (en) A method
PL3889374T3 (pl) Sposób wznoszenia budynków
EP3874072A4 (fr) Procédés d'extraction d'éléments d'une solution
GB201800558D0 (en) Method
SG11202100006QA (en) Method for isolating a cardiomyocyte population
ZA202109841B (en) Method for manufacturing mortar-based elements
IL286640A (en) A method for separating biomolecules
IL280423A (en) A method for identifying protein intermediates
SG11202105280QA (en) Method of identifying a structure
SG11202105311VA (en) Method of identifying a structure
GB201813722D0 (en) A method
GB2591080B (en) Extraction method
SG11202105294PA (en) Automated method of identifying a structure
SG10202000757YA (en) Confirming method
GB201813730D0 (en) A method
GB201908612D0 (en) A method for separating biomolecules
GB201809530D0 (en) A method
GB201808039D0 (en) A method
GB2594142B (en) A moulding method
GB201801169D0 (en) Method
GB201800187D0 (en) Method